KPI Therapeutics is a company that focuses on developing potentially game changing autoimmune therapies.
KPI Therapeutics is a company that focuses on developing potentially game changing autoimmune therapies. Its platform targets autoimmune diseasesautoimmune diseases of the skin that have millions of sufferers in the US and are a multi-billion-dollar market. Its lead drug, dalazatide, has completed Phase 1 trials and demonstrated clinical activity in patients.
KPI Therapeutics is a company that focuses on developing potentially game changing autoimmune therapies.
KPI Therapeutics is a company that focuses on developing potentially game changing autoimmune therapies. Its platform targets autoimmune diseases of the skin that have millions of sufferers in the US and are a multi-billion-dollar market. Its lead drug, dalazatide, has completed Phase 1 trials and demonstrated clinical activity in patients.
KPI Therapeutics is a company that focuses on developing potentially game changing autoimmune therapies.
KPI Therapeutics is a company that focuses on developing potentially game changing autoimmune therapies.